Cotellic 20 MG tablet 63S
Ended Awarded
- Contract number
- SPE2DB25FQWNZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,948
Award facts
- Contract value 100% obligated
- $9,948.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $9,948.13 by the Defense Logistics Agency (DLA) on July 24, 2025. The delivery order, which concludes on August 14, 2025, covers the supply of Cotellic 20 mg tablets (63 count), a prescription oncology medication. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal procurement market despite its small business status. The contract is executed under DLA's larger SPE2DB Indefinite Delivery Contract valued at $499,999,999 and extending through November 2026, which authorizes the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical products supporting military healthcare facilities.
DMS Pharmaceutical Group's established presence as a critical supplier in the federal pharmaceutical supply chain, evidenced by its SAM.gov registration since 2001 and consistent award history with DLA, positions the company as a reliable distributor of branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites nationwide. The SPE2DB vehicle enables efficient procurement of specialized pharmaceutical items, including oncology treatments such as Cotellic, ensuring that military health facilities maintain adequate pharmaceutical inventories to support patient care requirements across the global defense healthcare network.
Quick answers
Who was awarded contract SPE2DB25FQWNZ?
SPE2DB25FQWNZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FQWNZ worth?
The government has obligated $9,948 on SPE2DB25FQWNZ.
Is contract SPE2DB25FQWNZ an order under another contract?
Yes. SPE2DB25FQWNZ is a delivery order under SPE2DB25D9321, an indefinite delivery contract.
Was contract SPE2DB25FQWNZ competed?
The extent of competition for SPE2DB25FQWNZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award